Publicacions (41) Publicacions en què ha participat algun/a investigador/a

2003

  1. Avascular necrosis in HIV-infected patients receiving antiretroviral treatment: Study of seven cases

    HIV Clinical Trials, Vol. 4, Núm. 2, pp. 132-136

  2. Can drug resistance mutations influence the measurement of plasma HIV-RNA by different viral load techniques?

    AIDS Patient Care and STDs, Vol. 17, Núm. 7, pp. 321-324

  3. Changes in the human immunodeficiency virus p7-p1-p6 gag gene in drug-naive and pretreated patients

    Journal of Clinical Microbiology, Vol. 41, Núm. 3, pp. 1245-1247

  4. Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group

    New England Journal of Medicine, Vol. 349, Núm. 21, pp. 1993-2003

  5. Correlation between lopinavir plasma levels and lipid abnormalities in patients taking lopinavir/ritonavir

    AIDS Patient Care and STDs, Vol. 17, Núm. 9, pp. 443-445

  6. Desarrollo de sitios web para la oferta de servicios característicos de la Administración electrónica

    El profesional de la información, Vol. 12, Núm. 3, pp. 190-199

  7. Distribution of hepatitis B virus genotypes in HIV-infected patients with chronic hepatitis B: Therapeutic implications

    AIDS Research and Human Retroviruses, Vol. 19, Núm. 8, pp. 657-659

  8. Effectiveness of highly active antiretroviral therapy in Spanish cohorts of HIV seroconverters: Differences by transmission category

    AIDS, Vol. 17, Núm. 3, pp. 353-359

  9. First-line therapy and mitochondrial damage: Different nucleosides, different findings

    HIV Clinical Trials, Vol. 4, Núm. 1, pp. 11-19

  10. Gynecomastia in HIV-infected patients receiving antiretroviral therapy

    AIDS Research and Human Retroviruses, Vol. 19, Núm. 9, pp. 739-741

  11. HIV-positive immigrants in the Canary Islands, Spain: Implications for public health in Eurpoe

    HIV Clinical Trials, Vol. 4, Núm. 3, pp. 184-192

  12. High rate of resistance to antiretroviral drugs among HIV-infected prison inmates

    Medical Science Monitor, Vol. 9, Núm. 6

  13. Human immunodeficiency virus type 1 recombinant B/G subtypes circulating in Coimbra, Portugal

    Clinical Microbiology and Infection, Vol. 9, Núm. 5, pp. 422-425

  14. Hydroxyurea plus didanosine as maintenance therapy for HIV-infected patients on long-term successful highly active antiretroviral therapy

    HIV Clinical Trials, Vol. 4, Núm. 6, pp. 361-371

  15. Immunodetection of pneumolysin in human urine by ELISA

    Journal of Microbiological Methods, Vol. 54, Núm. 1, pp. 47-55

  16. Incidence of liver injury after beginning antiretroviral therapy with efavirenz or nevirapine

    HIV Clinical Trials, Vol. 4, Núm. 2, pp. 115-120

  17. Income taxes, spending composition and long-run growth

    European Economic Review, Vol. 47, Núm. 3, pp. 477-503

  18. Indinavir plasma concentrations and resistance mutations in patients experiencing early virological failure

    AIDS Research and Human Retroviruses, Vol. 19, Núm. 6, pp. 457-459

  19. Indinavir-induced thrombocytopenia

    AIDS Patient Care and STDs, Vol. 17, Núm. 3, pp. 103-104

  20. Interactions between nevirapine plasma levels, chronic hepatitis C, and the development of liver toxicity in HIV-infected patients

    AIDS Research and Human Retroviruses, Vol. 19, Núm. 3, pp. 187-188